245 related articles for article (PubMed ID: 23390305)
1. Immune responses to hepatitis C virus (HCV) infection and the prospects for an effective HCV vaccine or immunotherapies.
Lauer GM
J Infect Dis; 2013 Mar; 207 Suppl 1():S7-S12. PubMed ID: 23390305
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse model.
Wada T; Kohara M; Yasutomi Y
Vaccine; 2013 Dec; 31(50):5968-74. PubMed ID: 24144476
[TBL] [Abstract][Full Text] [Related]
3. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
Torresi J; Johnson D; Wedemeyer H
J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
[TBL] [Abstract][Full Text] [Related]
4. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
Neumann-Haefelin C; Thimme R
Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
[TBL] [Abstract][Full Text] [Related]
5. Designing an HCV vaccine: a unique convergence of prevention and therapy?
Walker CM
Curr Opin Virol; 2017 Apr; 23():113-119. PubMed ID: 28550816
[TBL] [Abstract][Full Text] [Related]
6. [The development of therapeutic vaccine for hepatitis C virus].
Kimura K; Kohara M
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1451-7. PubMed ID: 23064054
[TBL] [Abstract][Full Text] [Related]
7. [Immunology of hepatitis C: clinical significance of T cell response].
Shin EC
Korean J Hepatol; 2006 Jun; 12(2):140-53. PubMed ID: 16804339
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus-mediated modulation of cellular immunity.
Brenndörfer ED; Sällberg M
Arch Immunol Ther Exp (Warsz); 2012 Oct; 60(5):315-29. PubMed ID: 22911132
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for HCV infection: next steps.
Lang K; Weiner DB
Expert Rev Vaccines; 2008 Sep; 7(7):915-23. PubMed ID: 18767942
[TBL] [Abstract][Full Text] [Related]
10. A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.
Baumert TF; Fauvelle C; Chen DY; Lauer GM
J Hepatol; 2014 Nov; 61(1 Suppl):S34-44. PubMed ID: 25443345
[TBL] [Abstract][Full Text] [Related]
11. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C
Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664
[TBL] [Abstract][Full Text] [Related]
12. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.
Zhang S; Bakshi RK; Suneetha PV; Fytili P; Antunes DA; Vieira GF; Jacobs R; Klade CS; Manns MP; Kraft AR; Wedemeyer H; Schlaphoff V; Cornberg M
J Virol; 2015 Aug; 89(16):8304-17. PubMed ID: 26041301
[TBL] [Abstract][Full Text] [Related]
13. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.
Smyk-Pearson S; Tester IA; Lezotte D; Sasaki AW; Lewinsohn DM; Rosen HR
J Infect Dis; 2006 Aug; 194(4):454-63. PubMed ID: 16845628
[TBL] [Abstract][Full Text] [Related]
14. Immunity and hepatitis C: a review.
Terilli RR; Cox AL
Curr HIV/AIDS Rep; 2013 Mar; 10(1):51-8. PubMed ID: 23180007
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis C virus vaccine].
Wakita T
Nihon Rinsho; 2008 Oct; 66(10):1961-4. PubMed ID: 18939497
[TBL] [Abstract][Full Text] [Related]
16. Prospects for hepatitis C vaccine.
Bhopale GM; Nanda RK
Acta Virol; 2004; 48(4):215-21. PubMed ID: 15745044
[TBL] [Abstract][Full Text] [Related]
17. Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.
Feinstone SM; Hu DJ; Major ME
Clin Infect Dis; 2012 Jul; 55 Suppl 1():S25-32. PubMed ID: 22715210
[TBL] [Abstract][Full Text] [Related]
18. Advances in hepatitis C virus vaccines, Part one: Advances in basic knowledge for hepatitis C virus vaccine design.
Roohvand F; Kossari N
Expert Opin Ther Pat; 2011 Dec; 21(12):1811-30. PubMed ID: 22022980
[TBL] [Abstract][Full Text] [Related]
19. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
[TBL] [Abstract][Full Text] [Related]
20. Prospects for a vaccine against the hepatitis C virus.
Houghton M; Abrignani S
Nature; 2005 Aug; 436(7053):961-6. PubMed ID: 16107836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
